Energy development at the bottomHello trenders,
I show you today a solid company with strong backup and investors.
High potential on the upside, undervalued and part of utility sector it makes it a hot stock.
Given the circumstances in EU the price will go up starting by this winter.
Perfect for your portfolio diversification, good for short or long term.
Good luck.
Be wise don´t work for money, make money work for you.
Hotstock
Hot Stock to Buy from Ace Investment AdvisoryStrong Support near 2920
Buy Near 3035-3060 and on every dip
Target 3150/3200
Duration 1 Month
$DEFI About to break resistanceDEFI is hot right now, and should continue to climb.
The company has good products.
Good Luck.
BE Bloom Energy Corporation - Observe carefullyThis analysis is backed on Wyckoff ideas, technical analysis and overall market behavior.
BE is performing well since March 18th and 19th, it bounced over 2.94 both days, and since then it has been running up until July 16th. This day demand hit a wall, and that was reflected on the volume bar, which is one of the greatest volumes since January; this means that the stock got lateralised between the 19.50 to 11.69 (both rectangles). This represents an accumulation that has extended in time until October 6th , this day price "jumped over the creek" with a great volume that reflects demand supporting the movement. And until now it has been running up a few days, but with low volume , which means that the uptrend is going to go down (there's no one supporting the movement).
With all this past information, we can set out two thesis.
A) Prices will go down to the 19.45 area and pullback.
B) Prices will stop dropping down in the 21.69 area and pullback (a month support).
If no one of the thesis take place, prices would drop even further and we will have to look for a new support (mainly the gray lines which are monthly and weekly supports) But if not, we hope to see in the next few days a pullback to (19.45 or 21.69) in order to maintain the trend until prices hit a new resistance (which could be the 26.73 area, a month support)
This is just a global overview of the last days of BE. But all the most important info is in the chart.
Regards and have a great trade.
Investing in LIDAR (Driverless Vehicle Technology)Driverless vehicles are becoming a reality today because of a dramatic confluence of many technologies: computing power, cameras, sensors, laser range finders (called LIDAR), GPS, and artificial intelligence software, just to name a few.
But my team and I believe there are two companies responsible for by far the most “critical components” for the best self-driving cars.
The first company makes the most technologically advanced “brain” and “nervous system” for autonomous vehicles. This firm has already partnered with many of the leading companies in this space, including BMW, Hyundai, Audi, Intel, and Lyft, just to name a few.
This technology helped complete the longest automated drive ever… from San Francisco to New York City… and was selected by one national government to be the technology behind a country’s autonomous taxi’s set to hit the road in 2022.
This stock is still a great bargain today—and I strongly recommend you take a stake—I think you could make many times your money in the next few years.
The other key technology you want to own in the driverless technology space is the company that provides the computing power for many of today’s driverless vehicles.
The Walmart and the Tik Tok news could be a perfect mixThe daily chart under review has a whole lot going on, Wmt has been in its broader uptrend since its corona sell off/ rebound. This one shows alot of the breakdowns of price action. Lets put the past 6 weeks under review. The price action has ended in a seemingly cup and handle formation, typically which take around 6 weeks to form, this puts it at the right place at the right time if past trends continue. Currently nearing oversold on the RSI on a higher price level than it ever has been, gives an idea that it has earned strength in this area, and can be due for a push higher with good volume. If this one goes any lower, Id expect a bounce off the 50 day moving average. Good timing for tik tok news as this may be what WMT needs to push higher. Posted are resistance and support levels, with the purple levels signifying a change in action and possible pivot zones.
$4672.50 in 2006 to $6.00 - Huge Demand, Robust EarningsPacific Ethanol, Inc. produces and markets low-carbon renewable fuels and alcohol products in the United States. The company operates in two segments, Production and Marketing. It produces and markets ethanol; and co-products, such as wet and dry distillers grains, wet and dry corn gluten feed, condensed distillers solubles, corn gluten meal, corn germ, corn oil, dried yeast, and CO2, as well as markets ethanol produced by third parties. The company also offers ethanol transportation, storage, and delivery services through third-party service providers. It sells ethanol to integrated oil companies and gasoline marketers; distillers grains and other feed co-products to dairies and feedlots; and corn oil to poultry and biodiesel customers. The company owns and operates nine ethanol production facilities, including four plants located in the Western states of California, Oregon, and Idaho; and five plants in the Midwestern states of Illinois and Nebraska. Pacific Ethanol, Inc. was founded in 2003 and is headquartered in Sacramento, California.
I think this is the beginning of something huge. As I noted, the stock hit a high of $4672.50 in 2006.
Demand for Alcohol products in the United States and around the World is outstripping supply as can be seen in Pacific Ethanol's last earnings report below.
The company continues to pay down its debt too.
August 11, 2020
Shares of Pacific Ethanol (NASDAQ:PEIX) moved higher by 38.29% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 258.82% over the past year to $0.27, which beat the estimate of ($0.20). Revenue of $212,074,000 beat the estimate of $174,200,000.
This is a pure turnaround play in my opinion with a lot of room to run a lot higher.
Daily Chart is Bullish with most indicators trending up, Bullish
The stock continues to make new 52-week highs.
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Online Sports Betting Play & New Boyd ContractInternational Game Technology PLC operates and provides gaming technology products and services worldwide. The company operates through four segments: North America Gaming and Interactive, North America Lottery, International, and Italy. It designs, sells, and operates a suite of point-of-sale machines that reconciles lottery funds between the retailer and lottery authority; provides online lottery transaction processing systems; produces instant ticket games; and offers printing services, such as instant ticket marketing plans and graphic design, programming, packaging, shipping, and delivery services. The company also designs, develops, assembles, and provides cabinets, games, systems, and software for gamin market, as well as offers gaming management systems for casino management, customer relationship management, patron management, and server-based gaming. In addition, it provides video lottery terminals (VLT), VLT central systems, and VLT games; and amusement with prize machines and games to licensed operators. Further, the company offers sports betting services on sports and motor sports events, and non-sporting events, as well as sports betting technology and management services. Additionally, it provides digital gaming products and services, including poker, bingo, and online casino table and slot games; social casino content; and remote game server, as well as iGaming systems and digital platforms that offers player account management, advanced marketing and analytical, and payment system services. The company processes commercial transactions, such as prepaid cellular telephone recharges, bill payments, e-vouchers and retail-based programs, electronic tax payments, prepaid card recharges, and stamp duty and money transfers services. The company was formerly known as GTECH S.p.A. and changed its name to International Game Technology PLC in April 2015. The company was founded in 2014 and is headquartered in London, the United Kingdom. International Game Technology PLC operates as a subsidiary of De Agostini S.p.A.
IGT is known in the industry and is well respected.
The company started jumping into online sports betting. This is a hidden gem teaming up with some huge players / casinos. See news below.
IGT Announces Sports Betting Technology Agreement with Boyd Gaming
finance.yahoo.com
IGT, FanDuel Ink Multi-Year Sports Betting Deal, Shares Rise 7%
finance.yahoo.com
Target: $18 to $20 or higher
Weekly Chart looks like a Bull Flag
Daily Chart: Volume, PMO, MACD, RSI, OBV, Stochastic and Accumulation are trending up, Bullish
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Extreamly Undervalued - $10 Billion Stock Repurchase ProgramIntel Corporation provides computing, networking, data storage, and communication solutions worldwide. It operates through Data Center Group, Internet of Things Group, Non-Volatile Memory Solutions Group, Programmable Solutions Group, Client Computing Group, and All Other segments. The company offers platform products, such as CPU and chipset, system-on-chip, and multichip package products for cloud, enterprise, and communication infrastructure markets. It also provides NAND flash memory and DC persistent products for enterprise and cloud-based data centers, and users of business and consumer desktops and laptops; programmable semiconductors, such as field-programmable gate arrays, application-specific integrated circuits, and related products for communications, data center, industrial, and military markets; and various processors for notebooks, mobiles, and desktop PCs. In addition, it offers boards and systems, such as server boards and small form factor systems; and connectivity products for cellular modems, Ethernet controllers, silicon photonics, Wi-Fi, and Bluetooth. Further, the company develops computer vision and machine learning- based sensing, data analysis, localization, mapping, and driving policy technologies for advanced driver assistance systems and autonomous driving. It serves original equipment manufacturers, original design manufacturers, industrial and communication equipment manufacturers, and cloud service providers. The company was founded in 1968 and is headquartered in Santa Clara, California.
Great opportunity to buy the "KING" of the industry!
Intel announced a $10 Billion stock repurchase program.
The stock is undervalued at current levels especially compared to overpriced AMD.
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Online Learning in ChinaRYB Education, Inc. provides early childhood education service in the People's Republic of China. The company offers kindergarten services to 2-6-year-old children; and play-and-learn centers services for the joint participation of 0-6-year-old children and their adult family members to promote children's development, foster bonding with family, and prepare them for their entry into kindergartens and primary schools. It also develops and sells educational products and services, such as teaching aids, educational toys, at-home educational products, and school uniforms through franchisees and other business partners, as well as directly to a market of families. As of December 31, 2019, it operated 100 directly operated and 250 franchise kindergartens; and 6 play-and-learn centers. The company was formerly known as Top Margin Limited and changed its name to RYB Education, Inc. in June 2017. RYB Education, Inc. was founded in 1998 and is based in Beijing, China.
Daily Chart is Bullish
Broke out above the cloud yesterday.
Indicators are Bullish
Long
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Disposable Surgical Robotic Device - BIG News Coming 8/17/20Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Microbot Medical to Share Current Results of a Feasibility Animal Study Utilizing the LIBERTY Robotic System
Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference
HINGHAM, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference, being held on Monday, August 17, 2020, Microbot Medical Inc. (Nasdaq: MBOT), will provide initial results of a feasibility animal study performed using the Company’s LIBERTY Robotic System.
finance.yahoo.com
On 1/13/20, H.C. Wainwright maintained a Buy rating on MBOT and raised the price target from $12 to $26.00.
I think this device could be a game changer.
Disposable medical devices is where the future is going especially for sanitary reasons.
Watch this stock Monday, 8/17/2020, it could run hard.
I think the stock has been consolidating for a while and is coiling and ready to explode higher.
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Bitcoin Record Highs. Gold Record Highs. Launched in 2013, the BIT is sponsored by Alternative Currency Asset Management (ACAM), a wholly-owned subsidiary of SecondMarket Holdings, Inc. and an affiliate of SecondMarket, Inc. (custodian, marketing and distribution partner). ACAM has engaged leading service providers Ernst & Young (auditor).
Chart looks like this one is going to $17 to $20 real soon.
Daily Chart
PMO is spiking up, Bullish
Volume is Bullish
RSI is Bullish
MACD is Bullish
Accumulation is Bullish
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Beat Earnings. Raised Guidance. No Debt. USA Protective GearAlpha Pro Tech, Ltd., together with its subsidiaries, engages in developing, manufacturing, and marketing a line of disposable protective apparel and infection control, and building supply products in the United States and internationally. The company operates through two segments, Building Supply and Disposable Protective Apparel. The Building Supply segment offers construction weatherization products, such as house wrap, synthetic roof underlayment, and other woven materials. The Disposable Protective Apparel segment provides shoecovers, bouffant caps, gowns, coveralls, lab coats, hoods, and frocks, as well as face masks and face shields. The company provides its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; pharmaceutical markets; and building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.
Net Sales of $25.5 Million, an Increase of 123.4% Year-over-Year
Provides Update on Orders for Personal Protective Equipment (PPE)
Net sales for the second quarter of 2020 were $25.5 million, compared to $11.4 million for the second quarter of 2019, up 123.4% year-over-year.
Net income for the second quarter of 2020 was $6.2 million, or $0.46 per diluted share, compared to $1.0 million, or $0.08 per diluted share, for the second quarter of 2019, up 475% on a per share basis.
NOGALES, Ariz., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the three month period ended June 30, 2020.
finance.yahoo.com
Need I say anymore? Earnings blew past Wall Street Estimates. APT raised guidance and the company has no debt.
Protective gear and N95 masks will be a part of the Worldwide dress code through 2020 and into 2021 even if a vaccine is approved because not everyone will want to take the vaccine shot.
Today's sell off was outrageous and an early Christmas gift for anyone looking for a quality company that makes protective gear & N95 masks in the USA!
Target: $32
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Huge Earrings BeatDURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for pharmaceutical and medical device clients for use as raw materials in their products under the LACTEL brand. Its product pipeline consists of multiple investigational drug candidates in development, such as DUR-928, an endogenous, orally bioavailable small molecule that is in Phase I and II development stage to play a regulatory role in lipid homeostasis, inflammation, and cell survival. The company's oral and injectable delivery technologies are designed to enable new indications and enhanced attributes for small-molecule and biologic drugs, including POSIMIR, an investigational analgesic product intended to deliver bupivacaine to provide up to 3 days of pain relief after surgery. DURECT Corporation markets and sells its ALZET and LACTEL product lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Zogenix, Inc. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California.
This morning Durect reported earrings that blew away Wall Street Estimates.
Q2 EPS $0.07 Up From $(0.04) YoY, Sales $25 Million Beat $11.48 Million Estimate
Sales more than doubled estimates.
Daily Chart is Bullish
Indicators are rising, Bullish
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Rapid Recovery Respiratory Failure - COVID-19 TreatmentRelief Therapeutics Holding AG, a clinical stage biotechnology company, engages in developing treatment solutions for indications related to diabetic complications and respiratory diseases. The company is developing aviptadil, which has completed Phase II clinical trial for the treatment of sarcoidosis, an orphan pulmonary disease, as well as pulmonary hypertension; and atexakin alfa that has completed Phase I clinical trial to treat peripheral diabetic neuropathy. Relief Therapeutics Holding AG is based in Geneva, Switzerland.
RLF-100 (aviptadil) clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication in human lung cells
- Rapid recovery of patients on ventilators and ECMO (extracorporeal membrane oxygenation) was seen in patients with severe medical comorbidities after three days of treatment with RLF-100 under FDA Emergency Use IND authorization at multiple clinical sites
- Aviptadil is being developed as the first COVID therapeutic to block replication of the SARS-CoV-2 virus in human lung cells and monocytes
- RLF-100 is a patented formulation of aviptadil (synthetic human Vasoactive Intestinal Polypeptide VIP), which has been granted FDA Fast Track Designation, FDA emergency use IND authorization, and an expanded access protocol
finance.yahoo.com
I think this stock could spike like Moderna
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Plasma Play, FDA Approved Plasma FacilitiesADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
BREAKING NEWS TODAY - 07/30/2020
ADMA Biologics shares are trading higher following a report suggesting the company is near receiving emergency use authorization of Convalescent Plasma in COVID-19 patients.
www.benzinga.com
On July 6, 20, ADMA opened a new plasma facility and is awaiting emergency authorization for a second location.
finance.yahoo.com
With the FDA asking for everyone to donate plasma, this stock could rip!
Plasma stocks ripped today and continue to rip.
This company already is up and running one plasma facility.
Game On!
Long
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Coil, Pennant, Flag - Vans with DronesWorkhorse Group Inc. designs, manufactures, builds, sells, and leases battery-electric vehicles and aircraft in the United States. It operates through two divisions, Automotive and Aviation. The company also develops cloud-based and real-time telematics performance monitoring systems that enable fleet operators to optimize energy and route efficiency. Its products include electric cargo vans, and medium and light-duty pickup trucks, as well as HorseFly delivery drones systems. The company was formerly known as AMP Holding Inc. and changed its name to Workhorse Group Inc. in April 2015. Workhorse Group Inc. was founded in 2007 and is headquartered in Loveland, Ohio.
Today, there was an article on Dow Jones talking about Workhorse Pairing Vans with Drones to Drive Deliveries.
www.barrons.com
On 07/24/20, there was another article, "Trucks of the Future." & "Electric Trucks are the Future."
workhorse.com - Beautiful Electric Truck
On 07/23/20, Workhorse reported a purchase order for 20, C-1000 Electric Delivery Trucks.
On 07/21/20, Workhorse talks about supplying electric trucks to the Postal Service.
Does the news get any better?
Yes, on 07/14/20, Workhorse announces Ryder will now offer the C-1000 All-Electric Step Vans for rental locations.
On the Daily Chart, it looks to me like it's flagging, Bullish
To some, it might look like an uptrending coil or a Bullish Pennant.
No matter how you look at the daily chart, it looks to me like a very Bullish setup.
RSI is turning up, Bullish
OBV is turning up, Bullish
Stochastic is turning up, Bullish
Accumulation is Bullish
I see big things coming for this company!
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Moderna in Trouble - ABUS Wins Lawsuit Tied to COVID-19 DrugArbutus Biopharma Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of a cure for patients suffering from chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of AB-836, a capsid inhibitor that has the potential to inhibit HBV replication by preventing the assembly of functional viral capsids; and AB-423, which is in pre-clinical studies. The company also develops RNAi drugs, which utilize the RNA interference pathway, allows for a novel approach to treating disease. Its RNAi HBV candidates are designed to reduce hepatitis B surface antigen expression in patients chronically infected with HBV. In addition, it develops AB-729, a second generation RNAi therapeutic targeted to hepatocytes; HBV RNA destabilizer, an orally active agent that cause the destabilization of HBV RNAs, which leads to RNA degradation and to reduction in HBsAg levels. Further, the company engages conducting a Phase 1a/1b clinical trial and several pre-clinical and investigational new drug-enabling studies to evaluate proprietary HBV therapeutic agents, together with standard of care therapies, and in combination with each other. It has strategic alliance, licensing, and research collaboration agreements with Marqibo; Gritstone Oncology, Inc.; and Acuitas Therapeutics, Inc. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.
AFTER HOURS BREAKING NEWS
Moderna stock tumbled late Thursday after the biotech lost a patent battle that may jeopardize the financial future of its coronavirus vaccine.
Moderna (MRNA) challenged patents held by Arbutus Biopharma (ABUS) covering lipid nanoparticle, or LNP, technology. Lipid nanoparticles are the delivery system for messenger RNA drugs, including Moderna's coronavirus vaccine, which is known as mRNA-1273.
Despite the company's contention, the ruling could cut into profits on any Moderna drug, including mRNA-1273, says SVB Leerink analyst Mani Foroohar.
"Revenue concentration in (the coronavirus vaccine) is a central feature of the investment case for Moderna shares," Foroohar said. "Any meaningful royalty burden could hamper Moderna's pricing flexibility and margin profile vs. other players in the SARS-CoV-2 vaccine market."
Foroohar called the decision in Arbutus' favor "a disappointing turn for Moderna."
"This decision opens the door to a fascinating (and likely protracted) period of investor controversy and debate around the implications of any potential infringement of claims by Arbutus regarding Moderna's use of Lipid Nanoparticle delivery technology, and any further actions Moderna may take to defend their own (intellectual property) position and freedom to operate," he said.
NEWS: www.investors.com
Where's ABUS going? To $100.00 ...???
On the monthly chart, it looks like $9.00 might be the next stop..? At this point, I am not sure if there is a top right now for ABUS.
The news is huge for ABUS and could entitle ABUS to billions in profits and revenue from the COVID-19 vaccine.
Intelligent comments welcome.
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - FDA Grants Orphan Drug Designation for LymphomaMiragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high-unmet medical need. Its four lead product candidates include cobomarsen, an inhibitor of miR-155 for treating various blood cancers, such as cutaneous T-cell lymphoma, adult T-cell lymphoma/leukemia, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia; Remlarsen, a replacement for miR-29, a microRNA that is found at abnormally low levels in various pathological fibrotic conditions, including cutaneous and ocular fibrosis, which is in Phase II clinical trial; MRG-229, which is in preclinical trial for the treatment of idiopathic pulmonary fibrosis; and MRG- 110, an inhibitor of miR-92, a microRNA expressed in endothelial cells, which has completed two Phase I clinical trial for the treatment of heart failure, wound healing, and other ischemic disease in the United States and Japan. Miragen Therapeutics, Inc. was founded in 2006 and is based in Boulder, Colorado.
LATE BREAKING NEWS AFTER HOURS - POSSIBLY A BIG SPIKE IN THE MORNING
miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that the Food & Drug Administration (FDA) has granted orphan drug designation to cobomarsen, for the treatment of T-cell lymphoma.
DAILY CHART IS BULLISH
OBV is Bullish
MACD turned up Bullish
RSi crossed center line and turned up, Bullish
PMO is turning up, Bullish
This little stock could spike hard.
Best of luck everyone!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Robust Earnings, Undervalued & 7.79% YieldNavient Corporation provides education loan management and business processing solutions for education, healthcare, and government clients at the federal, state, and local levels in the United States. It operates through four segments: Federal Education Loans, Consumer Lending, Business Processing, and Other. The company holds and acquires Federal Family Education Loan Program loans that are insured or guaranteed by state or not-for-profit agencies; and performs servicing and asset recovery services on its own loan portfolio, and federal education loans owned by the United States Department of Education and other institutions. It also holds, originates, and acquires consumer loans; and performs servicing activities on its own education loan portfolio, including private education loans, and private education refinance loans. In addition, the company offers revenue cycle management and business processing services; and healthcare services that include revenue cycle outsourcing, accounts receivable management, extended business office support, and consulting engagement for federal, state, and municipal clients; public authorities; and healthcare organizations. Further, it provides customizable solutions for its clients that include hospitals, hospital systems, medical centers, large physician groups, and other healthcare providers; and corporate liquidity portfolio and debt repurchase services. The company was founded in 1973 and is headquartered in Wilmington, Delaware.
07/21/20, Navient Q2 Earnings Blew Away Wall Street Estimates
Daily Chart looks Bullish with indicators turning up, positive. BULLISH
The company has a current P/E of only 4.94x
Current EPS: $1.54
Yield: 7.79%
Reported Earnings: Q2 EPS $0.91 Beats $0.47 Estimate
Market Cap: 1.5 Billion
Institutional Ownership: 98.17%
In my opinion, the stock is DIRT CHEAP at current levels.
Compare this company's earnings to Bank of America & Wells Fargo, NAVI is blowing away Bank of America earnings along with many other large banks including Wells Fargo!
I think NAVI should be trading around $30.00 all day long with the earnings the company is delivering.
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Spotify Rumored Buyout of SONO - $4 Billion or more, Over $31Sonos, Inc., together with its subsidiaries, designs, develops, manufactures, and sells multi-room audio products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides wireless speakers, home theater speakers, components, and accessories. It offers its products through approximately 10,000 third-party retail stores, including custom installers of home audio systems; and e-commerce retailers, as well as through its Website sonos.com. The company was formerly known as Rincon Audio, Inc. and changed its name to Sonos, Inc. in May 2004. Sonos, Inc. was founded in 2002 and is headquartered in Santa Barbara, California.
"We are hearing from a European desk (Spotify is based in Sweden) that Spotify is preparing a roughly $4 billion bid to acquire home entertainment company Sonos (over $31 per share). There has been talk of an interest by Apple in Sonos, but the Sonos board is prepared to go ahead with Spotify. Dont know stock/cash terms."
Lets see what happens. Rumor SONO will be bought has been circulating for several months.
Today's price action tells us something is brewing!
Best of luck folks!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Vaccine Reduced COVID-19 into Common ColdAbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.
On 07/15/20, Researchers said AbbVie's Tricor reduced severity of COVID-19 into "NOTHING WORSE THAN A COLD."
www.yahoo.com
In my opinion, a vaccine doesn't get any better than this. AbbVie has the vaccine!
Where is all the great news about Tricor killing COVID-19.???
If the stock can break through around $107, I think it's going to spike hard!
The daily chart looks great.
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NIO ES6 - Amazing Vehicle! - Watch This VideoJust an FYI for NIO shareholders.
I thought you would be very interested in this video.
I also think this vehicle is a Tesla killer. I think China will eventually shut out Tesla & NIO will take over the Chinese Electric Vehicle Market.
www.youtube.com
Again, after watching stocks like SOLO, SPCE, WKHS, SHLL, SPAQ, NKLA, NFYEF & AYRO trade at crazy multiples with nothing to show for it, I think NIO is DIRT CHEAP!
In my opinion, NIO should be trading in the $50 to $100 range right now!
NIO is years ahead of the competition. I think it will take other electric vehicle companies several years to catch NIO.
Best of luck with your trades!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
